Surrey Heartlands

Joint Formulary & PAD

Delgocitinib - Hand eczema

You are here : Home > Formulary Search > Delgocitinib - Hand eczema

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

See narrative
Formulations :
  • Cream
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
NFD2
Restrictions / Comments :

This drug has not yet been assessed for formulary status.
It has not yet been evaluated by NICE or the Surrey Heartlands ICS Area Prescribing Committee (APC). As such, advice regarding safety, effectiveness (including cost-effectiveness) and its place in therapy is yet to be determined. 
Before prescribing this drug it is recommended that clinicians contact their Medicines Optimisation team to discuss possible alternatives/options.

NICE are due to publish guidance on this drug in Aug 2025 and this will be considered by the APC within 90 days of publication.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Delgocitinib
Indication :
Hand eczema
Group Name :
Keywords :
Brand Names Include :
Anzupgo
Important Information :

Not assessed for inclusion on the formulary. NICE guidance is anticipated in Aug 25. Advice will be updated post-NICE.

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Delgocitinib is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Hand eczema.

  • No records returned.

Committee Recommendations (0)

  • No records returned.